The NHS recommends that vaccination is the best protection for everyone from severe disease, risk of hospitalisation and death due to COVID-19.
There was concern that the vaccine may not be as effective for patients classified as clinically extremely vulnerable from COVID-19 due to underlying health conditions and/or the need to take anti-rejection medication (immunosuppression).
Analysis of data from Public Health England and NHS Blood and Transplant (NHSBT) strongly supports the recommendation that, in the absence of any other health contraindication, suitable transplant recipients and patients on the transplant waiting list should accept the offer of two doses of the vaccine for maximum protection against contracting or dying from COVID-19.
For more details, please click the link below:
